Our leadership team integrates deep experience in scientific research, drug development, agriculture and capital markets. Our team has significant experience in growing both public and private companies and creating value through innovative intellectual property, novel consumer products and ground-breaking services in the life sciences industry. This unique combination of assets are fundamental to Emerald’s emergence as a leading international cannabis firm.
Nick Leung2019-10-31T17:03:47+00:00
Nick Leung2019-10-31T17:05:06+00:00
Our directors across the group of companies have deep experience in pharmaceutical business development, academic research, public policy, and life sciences investing.
Nick Leung2020-04-28T13:58:18+00:00
Nick Leung2020-04-28T13:59:36+00:00
Nick Leung2018-10-02T13:08:00+00:00
